Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics

An agar disk elution method using round well plates, supplemented Mueller-Hinton agar, and commercial drug disks is described for susceptibility testing of Mycobacterium marinum and the rapidly growing mycobacteria to antibiotics and sulfonamides. By this method, 14 of 14 strains of M. marinum were susceptible to rifampin, doxycycline, minocycline, and trimethoprim-sulfamethoxazole. Identical results were obtained with Middlebrook 7H10 agar and drugs prepared from standard powders. With 58 isolates of Mycobacterium fortuitum and Mycobacterium chelonei, this method had a 92% correlation with broth minimal inhibitory concentration determinations for cefoxitin and greater than 98% for doxycycline, kanamycin, amikacin, and the sulfonamides. Sixty-nine percent of isolates of M. chelonei susceptible to amikacin on supplemented Mueller-Hinton agar were resistant on 7H10 agar, and 15 of 16 M. chelonei isolates susceptible to erythromycin in broth were resistant by disk elution when an endpoint of no growth was used with either agar. The agar disk elution method offers a practical method for testing of most antibacterial agents against these mycobacterial species.

[1]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[2]  R. Kim.  Tetracycline Therapy for Atypical Mycobacterial Granuloma , 1974 .

[3]  R. Wallace,,et al.  Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. , 1983, Annals of internal medicine.

[4]  M. Casal,et al.  In vitro susceptibility of mycobacterium fortuitum and mycobacterium chelonei to cefoxitin. , 1982, Tubercle.

[5]  R. Wallace,,et al.  In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria. , 1982, Reviews of infectious diseases.

[6]  H. Bodily,et al.  Drug susceptibility tests for tuberculosis using drug impregnated disks. , 1967, Technical bulletin of the Registry of Medical Technologists. American Society of Clinical Pathologists. Registry of Medical Technologists.

[7]  E. Wolinsky,et al.  Sporotrichoid Mycobacterium marinum infection treated with rifampin-ethambutol. , 1972, The American review of respiratory disease.

[8]  R. Wallace,,et al.  Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents , 1979, Antimicrobial Agents and Chemotherapy.

[9]  R. Irwin,et al.  Pulmonary infection with Mycobacterium chelonei: successful treatment with one drug based on disk diffusion susceptibility data. , 1982, The Journal of infectious diseases.

[10]  D. Welch,et al.  Antimicrobial Susceptibility Testing of Mycobacterium fortuitum Complex , 1979, Antimicrobial Agents and Chemotherapy.

[11]  S. Eykyn,et al.  The successful treatment of tropical fish tank granuloma (Mycobacterium marinum) with co‐trimoxazole , 1977, The British journal of dermatology.

[12]  M. Cynamon,et al.  In vitro susceptibility of Mycobacterium fortuitum to cefoxitin , 1981, Antimicrobial Agents and Chemotherapy.

[13]  K. Ryan,et al.  Stability of antibiotics and chemotherapeutics in agar plates. , 1970, Applied microbiology.

[14]  I. Krasnow,et al.  Preparation of tuberculosis susceptibility testing mediums by means of impregnated disks. , 1966, American journal of clinical pathology.

[15]  A. Bauer,et al.  THE DETERMINATION OF SULFONAMIDE SUSCEPTIBILITY OF BACTERIA. , 1964, Chemotherapia.

[16]  C. Sanders,et al.  In vitro sensitivity of Mycobacterium marinum to minocycline and doxycycline. , 1978, Tubercle.

[17]  R. Wallace,,et al.  Susceptibility of Mycobacterium marinum to tetracyclines and aminoglycosides , 1981, Antimicrobial Agents and Chemotherapy.

[18]  E. Wolinsky,et al.  In vitro susceptibility of Mycobacterium marinum to eight antimicrobial agents , 1980, Antimicrobial Agents and Chemotherapy.

[19]  R. Wallace,,et al.  Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. , 1981, Reviews of infectious diseases.

[20]  M. Bissett,et al.  Cooperative field test of drug-impregnated discs for susceptibility testing of mycobacteria. , 1971, The American review of respiratory disease.

[21]  C. Thornsberry,et al.  Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution , 1982, Antimicrobial Agents and Chemotherapy.

[22]  R. Good,et al.  Identification of clinically significant Mycobacterium fortuitum complex isolates , 1981, Journal of clinical microbiology.

[23]  P. Loria.  Minocycline hydrochloride treatment for atypical acid-fast infection. , 1976, Archives of dermatology.

[24]  R. Fass,et al.  Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 , 1979, Antimicrobial Agents and Chemotherapy.

[25]  R. Wallace,,et al.  Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei. , 1981, Reviews of infectious diseases.

[26]  G. Pankey,et al.  In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin. , 1978, The Journal of infectious diseases.